All News about Cybin Inc![]()
Psilera's DMT-Derived Drug Sees Positive Results in Pre-Clinical Study
December 09, 2021
Via Benzinga
Topics
Derivatives
Exposures
Derivatives
![]() ![]() ![]() ![]() ![]()
Cybin Announces FDA Approvals, Participation in Conference
December 01, 2021
Via Benzinga
Exposures
Product Safety
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]()
Use of Ketamine for Mental Disorders Rising While New Therapies Emerge
November 17, 2021
![]()
Cybin Reports Q2 Financial Results And Latest News, Including FDA & DEA Research Approvals
November 15, 2021
Via Benzinga
Exposures
Product Safety
![]()
Cybin Inc. Reports its Second Quarter Financial Results and Recent Business Highlights
November 15, 2021
From Cybin Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|